<DOC>
	<DOCNO>NCT00540085</DOCNO>
	<brief_summary>Aim : To optimize use rocuronium ( neuromuscular block agent ) obese patient undergo gastric bypass gastric banding . Background : During general anaesthesia , neuromuscular block agent need allow surgery airway management . Optimal dose important order avoid inadequately muscle relaxation , also avoid overdosage , result prolong anaesthesia respiratory complication . Main hypothesis : Rocuronium dose accord ideal body weight result short duration action compare rocuronium dose accord correct body weight without prolonged onset time compromise airway management surgical demand muscle relaxation .</brief_summary>
	<brief_title>Pharmacodynamic Trial Rocuronium Obese Patients</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<criteria>Age 1865 year . Elective laparoscopic gastric band gastric bypass . Expected difficult endotracheal intubation base anatomic pathologic finding history . Known suspected neuromuscular disease , know affect neuromuscular blockade . Severely impaired renal hepatic function , evaluate investigator . Known suspect allergy drug use trial . Daily expect use trial follow drug , know affect neuromuscular transmission : Inhalational anaesthetic , magnesiumsalts , clindamycin , polymyxins aminoglycosides ( gentamicin , neomycin , netilmicin , streptomycin og tobramycin ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>